+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Shrimp Disease Diagnostics Market - Global Forecast 2026-2032- Product Image
Shrimp Disease Diagnostics Market - Global Forecast 2026-2032- Product Image
New

Shrimp Disease Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5017278
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The shrimp disease diagnostics market is evolving as producers contend with higher biosecurity standards, shifting operational models, and the need for timely, reliable data. Senior decision-makers should recognize that aligning diagnostics with health management strategies is now essential for sustainable success in aquaculture.

Market Snapshot: Shrimp Disease Diagnostics Market

Valued at USD 507.54 million in 2025, the shrimp disease diagnostics market is set to grow to USD 539.33 million in 2026, ultimately reaching USD 894.80 million by 2032. Projected at an 8.43% CAGR, this upward trend underscores increased demand for advanced diagnostic solutions as global aquaculture markets prioritize disease control, production efficiency, and regulatory conformity. Effective diagnostics have shifted from being auxiliary tools to becoming central drivers of shrimp health and operational resilience. Enhanced investment and innovation within this sector are enabling stakeholders to implement faster, more accurate, and actionable health management strategies across the entire value chain. Regional advancements and technology adoption further drive market diversification, unlocking opportunities in both established and emerging shrimp-producing regions.

Scope & Segmentation

  • Technology: Key diagnostic platforms include Enzyme Linked Immunosorbent Assay (ELISA), Loop Mediated Isothermal Amplification, Next Generation Sequencing, and various types of Polymerase Chain Reaction (Multiplex PCR, Quantitative PCR, Reverse Transcription PCR), all supporting precision diagnostics and robust health monitoring.
  • Diagnostic Methods: The field covers histopathological diagnostics, immunological diagnostics such as ELISA, Lateral Flow Immunoassay, Western Blot, along with microbiological and molecular techniques, enabling comprehensive pathogen detection and disease characterization.
  • Applications: Major application areas include continual monitoring of shrimp populations, systematic outbreak investigations, fundamental research, and large-scale screening initiatives, each essential to maintain optimal production and meet regulatory requirements.
  • End Users: End users comprise academic institutions, aquaculture farms, diagnostic laboratories, and research institutes, reflecting a collaborative ecosystem addressing industry needs from education and research to applied farm operations.
  • Disease Types: Bacterial, fungal, parasitic, and viral diseases all fall within the market’s scope, necessitating tailored diagnostic approaches and management plans.
  • Regions: The market extends across the Americas, Europe, Middle East & Africa, and Asia-Pacific, with varying adoption rates and local regulatory environments shaping adoption and innovation.

Shrimp Disease Diagnostics Market: Key Takeaways

  • Technological convergence is leading to more portable, field-friendly diagnostic systems, providing rapid results at the point of need while easing the pressure on centralized testing facilities and speeding up health intervention timelines.
  • Integrated data and advisory services support smarter decision-making, enabling producers to proactively manage disease risks and align operational responses with real-time diagnostic feedback.
  • Adoption of advanced sequencing and bioinformatics tools empowers detailed pathogen surveillance, strengthening resistance monitoring and supporting customized intervention strategies.
  • Efforts toward assay standardization and protocol harmonization continue to be vital, with particular focus on validation and interoperability ensuring data integrity and comparability across global operations.
  • Stakeholders are emphasizing accessible, cost-efficient testing methods that expand utility to small and medium enterprises, broadening system-level disease management capacities.

Tariff Impact and Supply Chain Realignment

Ongoing tariffs on reagents, consumables, and essential equipment are prompting producers and laboratories to reconsider supply chain strategies. Procurement is diversifying, with regional manufacturing on the rise to reduce volatility and dependency. Investments in local validation and inventory management solutions are becoming more common, as is the adoption of open-source testing protocols. Collaborative supply arrangements are further supporting resilience amid fluctuating trade policies. This realignment is critical for sustaining consistent access to diagnostics and supporting uninterrupted health management in shrimp farming.

Methodology & Data Sources

The report leverages a mixed-methods approach. Structured reviews of peer-reviewed literature are synthesized with technical guidelines, while qualitative feedback from industry voices deepens practical insights. Findings are triangulated through assay validation studies and focused surveillance reports to anchor recommendations to current operational standards in laboratory and field settings.

Why This Report Matters

  • Equips executives with tactical guidance for investments in diagnostics technologies, workforce training, and system-wide deployment planning.
  • Identifies regional trends and operational drivers behind adoption, revealing gaps in capacity within established and emerging shrimp production geographies.
  • Clarifies the business case for integrating diagnostics, informatics, and advisory services, enhancing disease response and long-term shrimp health outcomes.

Conclusion

Future competitive advantage in shrimp aquaculture will depend on how effectively leaders integrate validated diagnostics with operational processes, robust data systems, and skilled teams. Strategic alignment of these elements will foster improved health management and sustainable production practices.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Shrimp Disease Diagnostics Market, by Technology
8.1. Enzyme Linked Immunosorbent Assay
8.2. Loop Mediated Isothermal Amplification
8.3. Next Generation Sequencing
8.4. Polymerase Chain Reaction
8.4.1. Multiplex PCR
8.4.2. Quantitative PCR
8.4.3. Reverse Transcription PCR
9. Shrimp Disease Diagnostics Market, by Diagnostic Method
9.1. Histopathological Diagnostics
9.2. Immunological Diagnostics
9.2.1. Enzyme Linked Immunosorbent Assay
9.2.2. Lateral Flow Immunoassay
9.2.3. Western Blot
9.3. Microbiological Diagnostics
9.4. Molecular Diagnostics
10. Shrimp Disease Diagnostics Market, by Disease Type
10.1. Bacterial Diseases
10.2. Fungal Diseases
10.3. Parasitic Diseases
10.4. Viral Diseases
11. Shrimp Disease Diagnostics Market, by Application
11.1. Monitoring
11.2. Outbreak Investigation
11.3. Research
11.4. Screening
12. Shrimp Disease Diagnostics Market, by End User
12.1. Academic Institutions
12.2. Aquaculture Farms
12.3. Diagnostic Laboratories
12.4. Research Institutes
13. Shrimp Disease Diagnostics Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Shrimp Disease Diagnostics Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Shrimp Disease Diagnostics Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Shrimp Disease Diagnostics Market
17. China Shrimp Disease Diagnostics Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. 3 Little Fish Sdn Bhd
18.6. Amazing Biotech
18.7. Aquaintech Inc.
18.8. Arachem (M) Sdn Bhd
18.9. Bioneer Corporation
18.10. Blue Aqua International Pte. Ltd.
18.11. CD Genomics
18.12. China Guangzhou BioKey Healthy Technology Co. Ltd
18.13. DSM Austria GmbH
18.14. Forte Biotech
18.15. GeneReach Biotechnology Corp.
18.16. GeneReach Biotechnology Corporation
18.17. Genics Pty. Ltd.
18.18. Illumina, Inc.
18.19. Innocreate Bioscience Co., Ltd.
18.20. Lab-Ind Resource Sdn. Bhd.
18.21. Laboratory Corporation of America Holdings
18.22. Mahesh Aqua Holdings (Pvt) Ltd.
18.23. Mylab Discovery Solutions Pvt. Ltd.
18.24. PT Riset Nusantara Genetika (Nusantics)
18.25. Randox Laboratories Ltd.
18.26. Reagen LLC
18.27. Ring Biotechnology Co Ltd.
18.28. Speedy Assay Sdn. Bhd.
18.29. SUREBIO
18.30. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY LOOP MEDIATED ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MULTIPLEX PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MULTIPLEX PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY QUANTITATIVE PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY QUANTITATIVE PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REVERSE TRANSCRIPTION PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY HISTOPATHOLOGICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY WESTERN BLOT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY WESTERN BLOT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MICROBIOLOGICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY BACTERIAL DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FUNGAL DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY PARASITIC DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY VIRAL DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY OUTBREAK INVESTIGATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY OUTBREAK INVESTIGATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY OUTBREAK INVESTIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE FARMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE FARMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. EUROPE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. EUROPE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 122. EUROPE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 123. EUROPE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 124. EUROPE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 125. EUROPE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 126. EUROPE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 127. EUROPE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 138. AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 139. AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 140. AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 141. AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 142. AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. ASEAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. ASEAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 155. ASEAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 156. ASEAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 157. ASEAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 158. ASEAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 159. ASEAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. ASEAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. GCC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GCC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 163. GCC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 164. GCC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 165. GCC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 166. GCC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 167. GCC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 168. GCC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. BRICS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. BRICS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 179. BRICS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 180. BRICS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 181. BRICS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 182. BRICS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 183. BRICS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 184. BRICS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. G7 SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. G7 SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 187. G7 SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 188. G7 SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 189. G7 SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 190. G7 SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 191. G7 SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 192. G7 SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. NATO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. NATO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 195. NATO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 196. NATO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 197. NATO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 198. NATO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 199. NATO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 200. NATO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 203. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 204. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 205. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 206. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 207. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 208. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 209. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 211. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 212. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 213. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2032 (USD MILLION)
TABLE 214. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY IMMUNOLOGICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 215. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 216. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 217. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Shrimp Disease Diagnostics market report include:
  • 3 Little Fish Sdn Bhd
  • Amazing Biotech
  • Aquaintech Inc.
  • Arachem (M) Sdn Bhd
  • Bioneer Corporation
  • Blue Aqua International Pte. Ltd.
  • CD Genomics
  • China Guangzhou BioKey Healthy Technology Co. Ltd
  • DSM Austria GmbH
  • Forte Biotech
  • GeneReach Biotechnology Corp.
  • GeneReach Biotechnology Corporation
  • Genics Pty. Ltd.
  • Illumina, Inc.
  • Innocreate Bioscience Co., Ltd.
  • Lab-Ind Resource Sdn. Bhd.
  • Laboratory Corporation of America Holdings
  • Mahesh Aqua Holdings (Pvt) Ltd.
  • Mylab Discovery Solutions Pvt. Ltd.
  • PT Riset Nusantara Genetika (Nusantics)
  • Randox Laboratories Ltd.
  • Reagen LLC
  • Ring Biotechnology Co Ltd.
  • Speedy Assay Sdn. Bhd.
  • SUREBIO
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 539.33 Million
Forecasted Market Value ( USD ) by 2032 $ 894.8 Million
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Shrimp Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Shrimp Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 239 Pages
  • Global
From
Animal Virus Detection Kit Market - Global Forecast 2026-2032 - Product Image

Animal Virus Detection Kit Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Animal Disease Diagnostic Kits Market - Global Forecast 2025-2030 - Product Image

Animal Disease Diagnostic Kits Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Equine Diagnostic Service Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Equine Diagnostic Service Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Veterinary Antimicrobial Susceptibility Testing Market in China - Product Image

Veterinary Antimicrobial Susceptibility Testing Market in China

  • Report
  • 150 Pages
  • China
From

About the Shrimp Disease Diagnostics Market

The Shrimp Disease Diagnostics market is a segment of the Animal Healthcare/Veterinary industry. It focuses on the diagnosis and treatment of diseases that affect shrimp, a type of crustacean. Diagnostic tests are used to identify the presence of disease-causing agents, such as bacteria, viruses, and parasites. These tests can be used to detect the presence of disease in shrimp, as well as to monitor the effectiveness of treatments. Diagnostic tests are also used to monitor the health of shrimp populations, as well as to detect the presence of disease-causing agents in the environment. The Shrimp Disease Diagnostics market is driven by the increasing demand for shrimp, as well as the need to ensure the health and safety of shrimp populations. The market is also driven by advances in technology, such as the development of new diagnostic tests and the use of molecular techniques. Companies in the Shrimp Disease Diagnostics market include Bio-Rad Laboratories, Thermo Fisher Scientific, QIAGEN, and Genetwister Technologies. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.